Lotus Pharmaceutical Co., Ltd. announced election of the following as directors: (1)Phannalin Mahawongtikul, Alvogen Emerging Markets Holdings Ltd. representative/Director at Lotus Pharmaceutical Co., Ltd.; (2)Oranee Tangphao, Alvogen Emerging Markets Holdings Ltd. representative/Director at Lotus Pharmaceutical Co., Ltd.; and (3)Yves Hermes, Alvogen Emerging Markets Holdings Ltd. representative/Director at Lotus Pharmaceutical Co., Ltd. Effective date of the new appointment is June 30, 2022.